We used γδ TCR-deficient (TCRδ -/-) mice to examine the role of γδ T cells for induction of mucosal responses and systemic tolerance to high versus low doses of oral antigen. When either TCRδ -/-or TCRδ ⍣/⍣ mice were immunized orally with a high dose of ovalbumin (OVA) prior to parenteral challenge, systemic IgG and IgE antibody responses were markedly reduced in both types of mice, while mucosal IgA responses were reduced only in the TCRδ -/-mice. Reduced T cell proliferative responses and delayed-type hypersensitivity were seen in TCRδ -/-and TCRδ ⍣/⍣ mice given the high dose of OVA. Antigen-induced T h 1 and T h 2 cytokine production by splenic CD4 ⍣ T cells was severely inhibited in orally tolerized TCRδ -/-and TCRδ ⍣/⍣ mice. In contrast, while oral tolerance associated with increased levels of IL-10 synthesis was induced by a low dose of OVA in TCRδ ⍣/⍣ mice, the TCRδ -/-mice were not tolerized and failed to produce IL-10. Our findings indicate that γδ T cells play a significant immunoregulatory role in IL-10-mediated, low-dose oral tolerance induction, but are not essential participants in the induction of systemic tolerance to orally introduced antigens given in larger doses.
Introduction
Oral administration of proteins or haptens can induce a state Current evidence suggests that T lymphocytes are the of systemic unresponsiveness (1). Sulzberger and Chase major cell type involved in the induction of mucosally induced established that oral administration of hapten inhibits contact tolerance (1). Oral administration of myelin basic protein hypersensitivity and this immunologic reaction still bears their (MBP) induced transforming growth factor (TGF)-β-producing name (2). In the early 1980s, this type of immunological CD8 ϩ T cells that were capable of inducing unresponsiveness response was dubbed oral tolerance and the concept used and inhibiting experimental autoimmune encephalomyelitis to refer specifically to immune responses elicited in mucosa-(5-7). Further, it was shown that experimental tracheal eosinoassociated as opposed to systemic tissues (3). In general, philia can be down-regulated by TGF-β-producing CD4 ϩ T oral administration of large amounts of antigen resulted in the cells (8). By contrast, CD4 ϩ T cells anergized by large doses induction of antigen-specific IgA responses in the mucosal of oral antigen feeding were implicated in the induction of compartment, whereas unresponsiveness to the same antigen antigen-specific systemic unresponsiveness (9). It has been was evident in the systemic immune system. Other recent suggested that T h 1-type cells are more sensitive to the studies have shown that nasal administration of proteins may induction of tolerance than T h 2-type cells (10,11). Thus, also induce systemic unresponsiveness (4), leading mucosal oral tolerance is possibly associated with selective downimmunologists to broaden the earlier term of oral tolerance to the more inclusive 'mucosally induced tolerance '. regulation of T h 1 cells which are more sensitive to tolerance induction by T h 2 cells via their respective cytokines in the of OVA in 100 µl of complete Freund's adjuvant (OVA/CFA) (Difco, Detroit, MI). For induction of low-dose oral tolerance, systemic immune compartment. However, recent studies have now shown that feeding high doses of ovalbumin (OVA) mice were gavaged with 2.5 mg of OVA or hen egg white lysozyme (HEL; Sigma) in 0.25 ml of PBS on days 0, 2 and inhibited production of both T h 1 (IL-2 and IFN-γ) and T h 2 (IL-4, IL-5 and IL-10) cytokines, and resulted in the reduction 5, then immunized s.c. on day 7 with OVA/CFA or 100 µg of HEL in 100 µl of CFA (HEL/CFA) (23) . Antigen-specific T and of IFN-γ-and IL-4-dependent, antigen-specific IgG2a and IgG1 antibody responses respectively (9). These findings B cell responses were determined 14 days after i.p. or 10 days after s.c. immunization. In some experiments, TCRδ ϩ/ϩ indicate that both T h 1 and T h 2 cell subsets are involved in the induction of oral tolerance. mice were treated by i.p. injection of anti-mouse γδ mAb (GL3, 200 µg/mouse) or hamster IgG as a control (Jackson The mucosal immune system possesses unique anatomical features and is composed of specialized subsets of lymphoid ImmunoResearch, West Grove PA) 3 days before oral administration of OVA or systemic immunization with OVA/ cells. Among the intestinal intraepithelial lymphocyte population, it is the CD8 ϩ T cell subset that is prevalent and CFA (23) .
γδ T cells comprise 30-50% of this population (12-15). Studies
Delayed-type hypersensitivity (DTH) responses of TCR-deficient mice suggest an important role for the γδ T cells in the immune responses to intracellular bacteria and Antigen-specific DTH responses were measured 7 and 14 days after systemic challenge by a standard protocol (25) . parasites (16) (17) (18) . The γδ T cells appear to be necessary for maintenance of mucosal IgA responses in the presence of Briefly, PBS (20 µl) containing 10 µg of antigen (OVA or HEL) was injected into the left ear pinna. Ear swelling was measured systemic unresponsiveness induced by oral immunization (19, 20) . Other studies have provided direct evidence for their 24 h later with a dial thickness gauge (Ozaki, Tokyo, Japan). The DTH response was expressed as the increase of ear influence on both IgA and IgE responses (4,21). These observations suggest that γδ T cells are a crucial functional swelling after antigen (e.g. OVA or HEL) injection following subtraction of swelling in the control site. component of the mucosal immune system. Indeed, recent reports indicate that γδ T cells are essential for the induction
Antigen-specific T cell responses of both low-and high-dose oral tolerance (22, 23) , although the mechanisms for the immunoregulatory role of γδ T cells
The spleen was removed aseptically and single cell suspensions prepared in RPMI 1640 (Cellgro Mediatech, Washington, in the induction of systemic unresponsiveness to low and high antigen doses still remain to be elucidated. DC) containing HEPES buffer, non-essential amino acids, sodium pyruvate, L-glutamine, penicillin/streptomycin and In order to address these issues, we have compared the immune responses in TCRδ -/-and in control mice given gentamycin (incomplete medium) (21) . CD4 ϩ T cells were purified by the MACS system (Stefen Milteny, Bergishdifferent doses of OVA orally prior to systemic challenge. The results indicate that systemic unresponsiveness to large doses Gladbach, Germany) as previously described (21) . Cells were passed through the magnetized column following incubation of ingested OVA is unimpaired in TCRδ -/-mice. In the case of low-dose tolerance, our data demonstrate that increased with biotin-labeled anti-CD4 mAb (GK 1.5) and streptavidinconjugated microbeads. The isolated CD4 ϩ T cells were levels of IL-10 production are associated with the presence of γδ T cells for the induction of systemic unresponsiveness.
Ͼ95% pure and Ͼ99% viable. To evaluate OVA or HEL responses, CD4 ϩ T cells were cultured with 1 mg/ml of OVA In contrast, low doses of proteins fail to induce IL-10-mediated tolerance in TCRδ -/-mice.
or HEL in the presence of feeder cells for 4 days. During the last 18 h of incubation, 0.5 µCi of [ 3 H]thymidine was added before the cells were harvested and the amount of incorporaMethods tion determined by scintillation counting. Control cultures were without antigen stimulation. In other experiments, lymphocytes γδ T cell-deficient mice isolated from spleen or intestinal epithelium of TCRδ ϩ/ϩ mice The derivation and initial characterization of TCRδ -/-mice fed low doses of OVA after 4 days of systemic challenge have been described previously (24) . TCRδ -/-mice used in were stained with FITC-conjugated anti-mouse γδ mAb (GL3; this study were maintained on a C57BL/6 (H-2 b ) background.
PharMingen, San Diego, CA) and then purified by flow The δ chain-deficient and normal mice (TCRδ ϩ/ϩ ) were maincytometry (Becton Dickinson, Oxnard, CA). The purified γδ T tained in Trexler isolators and remained pathogen-free. At cells (2.5ϫ10 5 -1ϫ10 6 ) were cultured with CD4 ϩ T cells 5-6 weeks of age, the mice were removed from the colony (2ϫ10 6 ) isolated from TCRδ -/-mice fed low doses of OVA in isolator unit, housed in micro-isolator cages in horizontal the presence of 1 mg of OVA and feeder cells for 7 or 14 laminar flow cabinets, and provided sterile food and water days. In some experiments, a double-chamber culture system ad libitum. The mice were between 7 and 10 weeks of age (Becton Dickinson, Franklin Lakes, NJ) was employed. The at the beginning of individual experiments.
purified γδ T cells (2.5ϫ10 5 -1ϫ10 6 ) were added to the upper well of the double chamber with CD4 ϩ T cells, feeder cells Immunization and OVA as described above. To establish systemic unresponsiveness to a high dose of Cytokine-specific ELISA and ELISPOT assays oral antigen, mice were given 25 mg of OVA (Fraction V; Sigma, St Louis, MO) dissolved in 0.25 ml of PBS by gastric Levels of cytokines in culture supernatants were measured by an ELISA, while the number of cytokine-secreting cells in intubation. Control mice received PBS only. Seven days later, mice were immunized via the i.p. systemic route with 100 µg CD4 ϩ T cell fractions was determined by cytokine-specific ELISPOT assays. The details of the ELISA and ELISPOT assays for IFN-γ, IL-2, IL-4, IL-5, IL-6 and IL-10 have been described previously (25) (26) (27) Spleens were aseptically removed and single-cell suspensions prepared (21) . Mononuclear cells in the lamina propria were isolated after removal of Peyer's patches from gene disruption on the efficiency with which oral administration the small intestine by the use of a combination of enzymatic of OVA induces unresponsiveness. When OVA-specific antidissociation and discontinuous Percoll gradients (Pharmacia, body levels in serum of TCRδ -/-mice and control mice of the Uppsala, Sweden) (21, 28) . Mononuclear cells in the interface same background (TCRδ ϩ/ϩ ; C57BL/6) were examined, both between the 40 and 75% layers were removed, washed, groups of mice given 25 mg of OVA orally had significantly and resuspended in RPMI 1640 containing 10% FCS. An reduced IgG responses following i.p. challenge when com-ELISPOT assay was employed to detect cells producing IgM, pared with mice given PBS only ( Fig. 1A , P Ͻ 0.004). Similar IgG and IgA antibodies (21) . Ninety-six well nitrocellulose results were obtained when mice were challenged by the s.c. plates (Millititer HA; Millipore, Bedford, MA) were coated with route (data not shown). On the other hand, reduced levels of 1 mg/ml of OVA (100 µl/well) in order to detect anti-OVA specific AFC (28) .
fecal IgA antibodies were seen in TCRδ -/-mice given OVA orally when compared with fecal IgA levels in TCRδ ϩ/ϩ mice Statistics fed the same antigen ( Fig. 1B , P Ͻ 0.003). These findings The significance of the difference (e.g. P values) between were confirmed at the single-cell level by using the ELISPOT groups was evaluated by the Mann-Whitney U-test using a assay. Prior oral administration of OVA also significantly Statview II program designed for Macintosh computers.
inhibited splenic IgG responses in TCRδ -/-and TCRδ ϩ/ϩ mice to subsequent parenteral immunization ( Fig. 2A , P Ͻ 0.001).
Results
The small intestinal lamina propria in both TCRδ -/-and TCRδ ϩ/ϩ Systemic B cell unresponsiveness in TCRδ -/-mice immunized mice contained OVA-specific IgA-producing cells, although orally with a large dose of OVA the number of these was significantly lower in TCRδ -/-mice than in normal controls ( Fig. 2B , P Ͻ 0.001). Oral administraIn order to investigate the potential role of γδ T cells in oral tolerance induction, we initially examined the effects of TCRδ tion of a large dose of protein antigen thus elicits reduced antigen-specific B cell responses in both systemic and incorporation for each control well was between 500 and 1000 c.p.m.
mucosal compartments of TCRδ -/-mice. T cells 3A, P Ͻ 0.002). However, OVA-specific IgE antibody responses were comparably reduced in the TCRδ -/-and Since T cell unresponsiveness was induced by oral administration of OVA to TCRδ -/-as well as in control mice, it was of control mice fed OVA prior to systemic immunization ( Fig. 3B , P Ͻ 0.002). Systemic IgE responses to protein antigens can interest to evaluate the T h 1 and T h 2 cytokine responses in orally tolerized mice. Purified CD4 ϩ T cells from the spleens therefore be inhibited in TCRδ -/-as well as in TCRδ ϩ/ϩ mice by prior oral administration of a protein antigen, at least in of TCRδ -/-mice previously fed OVA or PBS were incubated with or without 1 mg of OVA in the presence of autologous relatively high doses.
APC. Four days later, when the culture supernatants were Oral OVA (high-dose) administration diminishes DTH and T harvested and examined by cytokine-specific ELISA, cell proliferative responses in TCRδ -/-mice antigen-specific T h 1 (IFN-γ and IL-2) and T h 2 ( IL-4, IL-5, IL-6 and IL-10) cell responses were significantly reduced in We next determined whether or not oral administration of a protein antigen in relatively high doses similarly reduces TCRδ ϩ/ϩ mice given OVA (Table 1) . A virtually identical profile of down-regulation in cytokine synthesis was seen in the subsequent DTH responsiveness in TCRδ -/-mice. Twentyfour hours after intradermal OVA challenge, DTH responses TCRδ -/-mice following oral administration of OVA. To confirm these findings at the cellular level, the number of T h 1 and T h 2 were determined by measuring the ear swelling reaction in systemically immunized mice. Both TCRδ -/-and TCRδ ϩ/ϩ cytokine-producing cells was determined by cytokine-specific ELISPOT assays (Table 2 ). Splenic CD4 ϩ T cells from TCRδ -/-mice given PBS orally and then immunized parenterally showed significant ear swelling (50-60 µm) when the chalmice systemically immunized with OVA in CFA included significant numbers of IFN-γ-producing T h 1 type cells as well lenge dose of OVA (10 µg) was injected into the pinna. DTH responses were reduced comparably in both groups of mice as IL-4-, IL-5-, IL-6-and IL-10-secreting T h 2-type cells 4 days after in vitro antigen stimulation (Table 2) . Conversely, when given 25 mg of OVA via the oral route prior to systemic immunization ( Fig. 4A , P Ͻ 0.02). Having established that TCRδ -/-mice received a tolerizing dose of OVA before parenteral challenge, the numbers of antigen-specific cytokine-DTH responses were compromised in TCRδ -/-mice fed a relatively high dose of OVA, we examined the proliferative producing cells were greatly reduced for both T h 1 and T h 2 types of cytokines, and similar results were obtained for the response of their T cells to OVA. Splenic CD4 ϩ T cells were cultured for 4 days with antigen-presenting cells (APC) in the TCRδ ϩ/ϩ control mice (Table 2 ). These data indicate that T h 1 and T h 2 types of systemic responses are comparably downpresence of OVA. Relatively low levels of T cell proliferation were observed for splenic CD4 ϩ T cells from OVA-tolerized regulated in TCRδ -/-and control mice by prior oral administration of a large dose of protein antigen. TCRδ -/-mice and TCRδ ϩ/ϩ mice, whereas relatively vigorous proliferative responses were observed for splenic CD4 ϩ T Low doses of oral OVA fail to induce systemic cells from control TCRδ -/-and TCRδ ϩ/ϩ mice given saline unresponsiveness in TCRδ -/-mice orally (Fig. 4B) . The systemic hyporesponsiveness induced by the oral administration of a large dose of OVA is thus
Since repeated oral administration of relatively low doses of antigen can elicit systemic tolerance, the role of γδ T cells evident at the T cell level in TCRδ -/-mice. 
a Splenic CD4 ϩ T cells (2 ϫ 10 6 /ml) from each group of mice were cultured with 1 mg/ml of OVA in the presence of T cell-depleted and irradiated splenic feeder cells (4 ϫ 10 6 /well).
b Culture supernatants were harvested following 4 days (2 days for IL-2) of incubation and analyzed by the respective cytokine-specific ELISA. a Splenic CD4 ϩ T cells (2 ϫ 10 6 /ml) from each group of mice were cultured with 1 mg/ml of OVA in the presence of T cell-depleted and irradiated splenic feeder cells (4 ϫ 10 6 /well).
b Non-adherent cells were harvested following 4 days of incubation and analyzed by the respective cytokine-specific ELISPOT assays. c Results represent values (mean Ϯ SEM) from three separate experiments.
was assessed in this form of oral tolerance. Both TCRδ -/-and TCRδ ϩ/ϩ mice were fed three doses of 2.5 mg of OVA prior to challenge by the parenteral (s.c.) route. TCRδ ϩ/ϩ mice showed lower anti-OVA IgG antibody responses in serum than did mice given oral PBS ( Fig. 5A , P Ͻ 0.02). Splenic IgG AFC were also reduced in the TCRδ ϩ/ϩ mice ( Fig. 5B , P Ͻ 0.004). In contrast, no differences in serum IgG anti-OVA antibody or splenic IgG AFC responses were observed between control and oral feeding groups of TCRδ -/-mice.
OVA-specific T cell responses were also assessed in TCRδ -/-and TCRδ ϩ/ϩ mice given small oral doses of antigen. Oral administration of small doses of OVA prior to systemic challenge resulted in diminished ear swelling or DTH (P Ͻ 0.004) in TCRδ ϩ/ϩ mice but not in TCRδ -/-mice (Fig. 6A) . A these results suggest that the γδ T cells are essential for the culturing CD4 ϩ T cells for 4 days followed by measurement 14.5 Ϯ 0.5 ). These results, indicating a lack of mucosally of cytokines in the supernatants. The major difference induced low-dose tolerance in TCRδ -/-mice, were confirmed observed in cytokine responses of TCRδ -/-and TCRδ ϩ/ϩ mice by the observation of normal DTH and T cell proliferative involved IL-10 production. Although none of the experimental responses in these mice (data not shown). These findings groups produced IL-10 without in vitro antigen stimulation, indicate the absence of low-dose oral tolerance in TCRδ -/-splenic CD4 ϩ T cells from TCRδ ϩ/ϩ mice fed multiple small mice is antigen-specific.
doses of OVA prior to systemic immunization produced elevated levels of IL-10 when compared with TCRδ ϩ/ϩ mice Dose-dependent mucosally induced tolerance in anti-γδ mAbgiven PBS only (Table 3 , P Ͻ 0.03). In contrast, CD4 ϩ T cell treated TCRδ ϩ/ϩ mice IL-10 synthesis was significantly low in TCRδ -/-mice given In order to examine whether or not dose-dependent mucosally small oral doses of OVA, although IL-10 production by CD4 ϩ T induced tolerance is related to ontogenetic abnormalities in cells from control TCRδ -/-and TCRδ ϩ/ϩ mice was comparable. TCRδ -/-mice, a series of experiments were performed with These results were confirmed at the RNA level by quantitative TCRδ ϩ/ϩ mice treated with anti-γδ mAb. The anti-γδ treated RT-PCR analysis of IL-10 transcripts (data not shown). When TCRδ ϩ/ϩ mice fed a high dose of OVA prior to systemic production of other cytokines was examined, significant immunization showed reduced IgG antibody responses when differences were not seen between the levels produced by compared with anti-γδ treated TCRδ ϩ/ϩ mice given oral PBS CD4 ϩ T cells from TCRδ -/-and TCRδ ϩ/ϩ mice. These findings only ( Fig. 7A , P Ͻ 0.02). In contrast, when anti-γδ treated suggest that IL-10 production may play an important role in TCRδ ϩ/ϩ mice were fed low doses of OVA, no reduction of low-dose oral tolerance induction and that γδ T cells may the anti-OVA IgG antibody response was seen. A similar regulate this response by CD4 ϩ T cells. pattern of responses was noted at the T cell level. Thus, antiIn order to examine a possible role for TGF-β in the induction γδ treated TCRδ ϩ/ϩ mice fed low doses of OVA resulted in and maintenance of low-dose oral tolerance, we measured the maintenance of DTH and T cell proliferative responses levels of TGF-β in CD4 ϩ T cell cultures from orally treated after systemic challenge with OVA/CFA. On the other hand, TCRδ -/-and TCRδ ϩ/ϩ mice. The levels of TGF-β did not these T cell responses were markedly reduced in anti-γδ increased in culture supernatants of splenic CD4 ϩ T cells treated TCRδ ϩ/ϩ mice given a high oral dose of OVA (Fig. 7B after OVA stimulation, suggesting that TGF-β may not have and C, P Ͻ 0.004 and P Ͻ 0.02 respectively). These results an effect on the induction of systemic unresponsiveness by confirmed the dose-dependent γδ T cell requirement for mucosally induced tolerance observed in TCRδ -/-mice.
low doses of oral OVA. IL-10 (ng/ml) (U/ml) (pg/ml) (U/ml) (ng/ml) (pg/ml) a Splenic CD4 ϩ T cells (2 ϫ 10 6 /ml) from TCRδ -/-mice fed low doses of OVA were cultured with 1 mg/ml of OVA in the presence of T celldepleted and irradiated splenic feeder cells (4 ϫ 10 6 /well).
b Culture supernatants were harvested following 7 and 14 days of incubation and analyzed by IL-10 specific ELISA. The control wells without antigen stimulation and those with γδ T cells alone contained 13.1 Ϯ 4.1 and 4.4 Ϯ 0.2 pg/ml of IL-10 respectively. c γδ T cells (2.5 ϫ 10 5 -1 ϫ 10 6 /well) from spleen or IEL of TCRδ ϩ/ϩ mice fed low doses of OVA were added into CD4 ϩ T cell cultures (Direct). In some cases, γδ T cells were added to the upper well of double chamber plate (Indirect). The levels of IL-10 were statistically increased (P Ͻ 0.03) in comparison to the cultures without γδ T cells.
d Results represent the value (mean Ϯ SEM) from three separate experiments. e Not determined. *P ϭ 0.02.
γδ T cells can up-regulate IL-10 synthesis in CD4 ϩ T cells
TCRδ -/-mice. Increased levels of IL-10-specific mRNA from TCRδ -/-mice fed low doses of OVA expression in CD4 ϩ T cells but not in γδ T cells after 7 days of culture further confirmed our findings (data not shown). In order to address the potential role of γδ T cells in the Interestingly, when direct cell-cell interactions between γδ T induction of IL-10-mediated low-dose tolerance, γδ T cells cells and CD4 ϩ T cells were prevented by using a doubleand CD4 ϩ T cells respectively were isolated from TCRδ ϩ/ϩ chamber well system, reduced IL-10 production was noted and TCRδ -/-mice previously fed low doses of OVA. These T (Table 4) . Splenic γδ T cells in the trans-well system showed cell subsets were cultured separately, mixed together or marked decreases in IL-10 production when compared with separated by filters in the presence of antigen and feeder direct cell-cell contact cultures (Table 4 , P Ͻ 0.02). These cells for 7 or 14 days. The culture supernatants were harvested results provide direct evidence that γδ T cells serve an and IL-10 levels were examined by ELISA. The control wells immunoregulatory role for CD4 ϩ T cells of IL-10 production without antigen stimulation and those with γδ T cells alone under conditions of low-dose oral tolerance. The present contained 13.1 Ϯ 4.1 and 4.4 Ϯ 0.2 pg/ml of IL-10 respectively.
findings further suggest that both soluble factors produced The levels of IL-10 production by CD4 ϩ T cells were increased by γδ T cells and cell-cell interactions between γδ T cells and in the presence of γδ T cells from spleen or intestinal epithelium CD4 ϩ T cells are essential for maximum IL-10 synthesis which of OVA fed and immunized (Table 4 , P Ͻ 0.03), but not by γδ T cells taken from naive mice or from high-dose tolerant leads to an inhibition of systemic immune responses.
Discussion demonstration that treatment of mice with anti-γδ TCR antibodies does not eliminate γδ T cells, but instead leads The results of the present study indicate that the role of γδ T indirectly to the activation of recipient αβ T cells (33, 34) . It is cells in oral tolerance depends on the antigen dose. The therefore possible that while γδ T cells are non-essential for γδ T cells are not required for the systemic B or T cell the induction of tolerance to antigens administered by mucosal unresponsiveness by relatively high doses of orally adminisroutes, they may still play an active role in this process under tered antigen. To the contrary, this T cell subset regulates certain natural and experimental conditions. Our results in low-dose oral tolerance via modulation of IL-10 production TCRδ -/-mice and in an anti-γδ mAb treatment system have by CD4 ϩ T cells. This antigen dose-dependent regulatory provided evidence that γδ T cells may indeed play distinct dichotomy provides an interesting paradox with regard to the roles in the induction of orally induced tolerance depending local function of intestinal γδ T cells in oral antigen responses.
on the dose of antigen. Specifically, our data indicates that The sentinel location and increased numbers of γδ T cells in low-dose oral tolerance requires γδ T cells for development of the intestinal epithelium intuitively suggest a significant role the systemic unresponsiveness and high-dose oral tolerance in the responses to orally administered antigens. Their does not. absence has been associated with the loss of certain epithelial
The difference in outcomes between the present studies cell functions (29) and to the diminishment of mucosal IgA and those of Ke et al. (23) , are not easily reconciled. These responses to oral antigens (21), a finding confirmed in the investigators found that TCRδ -/-mice were refractory to present studies. The absence of the γδ T cell subset would tolerance induction by various doses of oral antigen as therefore be expected to influence the immunologic homeoassessed by reduction in IgG antibody responses, and T stasis pathway involved in mucosally induced hypocell proliferative and cytotoxic T lymphocyte responses to responsiveness and our present findings indeed indicate subsequent systemic immunization. The resolution of this compromised oral tolerance in TCRδ -/-mice given relatively discrepancy must await additional studies. However, a second low doses of OVA. We further demonstrated that γδ T cells potentially important difference in the present study and those are able to up-regulate IL-10 synthesis in TCRδ ϩ/ϩ mice of other investigations (23) is the manner in which oral tolerized with low oral antigen doses. This finding provides tolerance was induced by oral feeding. This is a significant direct evidence that γδ T cells regulate IL-10 synthesis by consideration since the mechanisms involved in mucosally CD4 ϩ T cells in the induction of low-dose oral tolerance. Our induced tolerance may differ according to the antigen dose results also confirm studies in which γδ T cells were shown (1). Indeed, we found systemic tolerance was not induced in to regulate the induction and maintenance of systemic TCRδ -/-mice pre-administered orally with multiple small doses tolerance to antigens administered via oral (22, 23) , respiratory of OVA, but was induced in identically treated TCRδ ϩ/ϩ mice. mucosa (4) or portal vein routes (30,31).
Prolonged oral administration or feeding with doses of antigen In striking contrast, the present results indicate that systemic can selectively activate CD4 ϩ or CD8 ϩ T cells which secrete tolerance following oral antigen administration can be induced suppressive cytokines, e.g. TGF-β, IL-4 and IL-10, that may normally by relatively high antigen doses in the complete down-regulate antigen-specific immune responses (1). In absence of γδ T cells. Equivalent reductions in systemic IgG tolerance induced by small doses of oral antigen, γδ T cells and IgE antibody responses, DTH, T cell proliferation, and may contribute to unresponsiveness by the production of both T h 1 and T h 2 cytokine responses to OVA were all seen in TGF-β, considered to be a key cytokine for the induction of both TCRδ -/-and TCRδ ϩ/ϩ mice fed with this antigen prior to active suppression (35). However, we could not demonstrate parenteral immunization. The same results were observed in an inhibitory effect for TGF-β for the induction of low-dose experiments in which TCRδ ϩ/ϩ mice were given anti-γδ mAb oral tolerance. Instead, in the present study, splenic CD4 ϩ T treatment. Moreover, TNBS and oxazolone feedings induced cells in TCRδ ϩ/ϩ mice given low doses of OVA produced tolerance to contact sensitization in TCRδ -/-mice (data not higher levels of IL-10 than did those of non-tolerized TCRδ ϩ/ϩ shown). Although these results differ from those of similar mice, while those from TCRδ -/-mice fed low doses of OVA studies in a previous report (22) , others have shown that γδ failed to produce IL-10. A recent study showed that regulatory T cells are not essential for the induction of aerosol-induced CD4 ϩ T cell clones which selectively produce IL-10, termed IgE unresponsiveness to OVA (32) . We conclude that, whereas T regulatory cell 1 (T r 1), can dramatically reduce T cell the γδ T cells are required for normal mucosal epithelial proliferative responses (36). This T cell subset was found to be function and IgA responsiveness (21,31), they do not play an responsible for preventing the development of inflammatory obligatory role in the establishment of high-dose oral or bowel disease in a mouse model (36). These results support mucosally induced tolerance.
the importance of IL-10 production for induction of low-dose A major difference between earlier studies of γδ T cell oral tolerance. The present results indicate that γδ T cells are involvement in oral tolerance and the present ones involved able to up-regulate the synthesis of this important cytokine the manner in which the γδ T cells were manipulated. Some by CD4 ϩ T cells. The γδ T cells may thus induce IL-10 studies have relied primarily on anti-γδ mAb treatment of producing regulatory CD4 ϩ T cells that can limit systemic mice (22, 23) , while others involved the transfer of antigenimmune responses in mice primed with low oral antigen doses. stimulated γδ T cells to naive recipients (4,23,30,31). Engage-
The findings obtained in a trans-well response system ment of the γδ T cells via their TCR was a common feature in provide evidence indicating that both soluble factors promost of these experiments and one proposed mechanism for duced by γδ T cells and direct cell-cell interactions are the tolerization was the production of inhibitory cytokines by essential for maximum IL-10 production. Monocyte chemotactic protein (MCP)-1, a CC chemokine, is a candidate the γδ T cells (31). This possibility gains support from the soluble factor for the induction of IL-10 synthesis. In support participants in the induction of systemic unresponsiveness to high doses of orally ingested antigen. of this idea, MCP-1 enhanced T h 2-type cytokine responses when transgenic T cells were stimulated via the TCR-CD3 complex (37). MCP-1 may also play an immunoregulatorystudy has shown that intestinal intraepithelial γδ T cells stimulated with IL-7 and stem cell factor expressed mRNA specific Abbreviations for MCP-1 (manuscript in preparation). Our current findings or clonal deletion (1,40). In accordance with this outcome, our
